ArticleFrontiers in oncology2025

Commentary: Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial.

Shuyan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.